Cellbyte Raises $2.75M to Accelerate Drug Launches with AI-Native Platform
What You Should Know:
– Cellbyte, the AI-native platform that helps pharmaceutical companies accelerate drug launches, announces that it has raised $2.75 million in seed funding.
– The round was led by Frontline Ventures, with participation from…
Continue Reading
